Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-16
2005-08-16
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S326000, C514S343000, C514S654000, C514S813000
Reexamination Certificate
active
06930122
ABSTRACT:
The invention relates to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide for helping to quit tobacco consumption.
REFERENCES:
patent: 5624941 (1997-04-01), Barth et al.
patent: 6344474 (2002-02-01), Maruani et al.
patent: 2002/0128302 (2002-09-01), Maruani et al.
patent: 0 656 354 (1995-06-01), None
patent: WO 98/32441 (1998-07-01), None
patent: WO 00/46209 (2000-08-01), None
Jorenby et al., A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch ot Both for Smoking Cessation, 1999, New England Journal of Medicine, vol. 340, No. 9, pp. 685-691.
Fowler et al., Brian Monoamine Ocidase A Inhibition in Cigarette Smokers, 1996, Proceedings of the National Academy of Science, vol. 93, pp. 14065-14069.
H. Kobayashi et al., Journal of Toxicological Sciences, vol. 24, No. 1, pp. 1-16, 1999.
F. Rodriguez de Fonseca et al., Acta Pharmacol Sim, vol. 20, No. 12, pp. 1109-1114, 1999.
G.J. Molderings et al., Fundamental Clinical Pharmacology, vol. 12, No. 4, pp. 388-397, 1998.
Blanchard Jean Charles
Menard François
Gupta Balaram
Krass Frederick
Lewis Amy A.
Sanofi-Aventis
LandOfFree
Use of central cannabinoid receptor antagonist for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of central cannabinoid receptor antagonist for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of central cannabinoid receptor antagonist for preparing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3497871